In vitro and In vivo anti-microbial effects of Nigella sativa linn. Seed extracts against clinical isolates from skin wound infections

American Journal of Applied Sciences

Volumn 6, Issue 8, 2009, Pages 1440-1447

  Abu Al Basal, Mariam A ^a  

^a AL AL BAYT UNIVERSITY   (Jordan)

Author keywords

Clinical isolate; Fixed oil; Nigella sativa; Skin wound; Staphylococcal infection

Indexed keywords

EID: 77951042651     PISSN: 15469239     EISSN: 15543641     Source Type: Journal    
DOI: 10.3844/ajassp.2009.1440.1447     Document Type: Article

References (33)

1. Goreja, W.G., 2003. Black Seed: Nature's Miracle Remedy. Amazon Herbs Press, New York, ISBN: 0- 9742962-1-X, pp: 54.
2. Schleicher, P. and M. Saleh, 2000. Black Cumin: The Magical Egyptian Herb for Allergies, Asthma, Skin Conditions and Immune Disorders. Healing Arts Press, Rochester, Vermont, ISBN: 0-89281-843-3, pp: 31-85.
3. El Tahir, K.E.H. and D.M. Bakheet, 2007. The black seed Nigella sativa linnaeus-a mine for multi-cures: A plea for urgent clinical evaluation of its volatile oil. J. T. U. Med. Sci., 1: 1-19. http://faculty.Ksu.edu.sa/60161/Publications/Publications/TheBlackSeed.p df
4. Ali, B.H. and G. Blunden, 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res., 17: 299-305. http://www.ncbi.nlm.nih.gov./pubmed/12722128
5. Burits, M. and F. Bucar, 2000. Anti-oxidant activity of Nigella sativa oil. Phytother. Res., 14: 323-328. http://www.ncbi.nlm.nih.gov./pubmed/10925395
6. Amara, A.A., M.H. El-Masry and H.H. Bogdady, 2008. Plant crude extracts could be the solution: Extracts showing in vivo anti-tumorigenic activity. Pak. J. Pharm. Sci., 21: 159-171. http://www.ncbi.nlm.nih.gov./pubmed/18390447
7. Kumara, S.S. and B.T. Huat, 2001. Extraction, isolation and characterization of anti-tumor principle, alpha-hederin, from the seeds of Nigella sativa. Planta. Med., 67: 29-32. http://www.ncbi.nlm.nih.gov./pubmed/11270717
8. El-Wakil, S.S., 2007. Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates. J. Egypt Soc. Parasitol., 7: 801-813. http://www.ncbi.nlm.nih.gov./pubmed/18383782
9. Salem, M.L., 2005. Immunomodulatory and therapeutic properties of the Nigella sativa L. Seed. Int. Immunopharmacol., 5: 1749-1770. http://www.ncbi.nlm.nih.gov./pubmed/16275613
10. Rchid, H., H. Chevassus, R. Nmila, C. Guiral, P. Petit, M. Chokairi and Y. Sauvaire, 2004. Nigella sativa seed extracts enhance glucose-induced insulin release from rat-isolated langerhans islets. Fundam. Clin. Pharmacol. 18: 525-529. http://www.ncbi.nlm.nih.gov./pubmed/15482373
11. Uz, E., O. Bayra, E. Uz, A. Kaya and R. Baayrak et al., 2008. Nigella sativa oil for prevention of chronic cyclosporine nephrotoxicity: An experimental model. Am. J. Nephrol., 28: 517-522. DOI: 10.1159/000114004
12. Nagi, M.N., K. Alam, O.A. Badary, O.A. Shabanah, H.A. Al-Sawaf and A.M. Al-Bekairi, 1999. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an anti-oxidant mechanism. Biochem. Mol. Biol. Int., 47: 153-159. http://www.ncbi.nlm.nih.gov./pubmed/10092955
13. Rashed, A.N., F.U. Afifi and A.M. Disi, 2003. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J. Ethnopharmcol., 88: 131-136. DOI: 10.1016/S0378-8741(03)00194-6
14. Hanafy, M.S. and M.E. Hatem, 1991. Studies on the anti-microbial activity of Nigella sativa seed (black cumin). J. Ethnopharmacol., 34: 275-8. http://www.medscape.com/medline/abstract/1795532
15. Mashhadian, N.V. and H. Rakhshandeh, 2005. Anti-bacterial and anti-fungal effects of Nigella sativa extracts against S. aureus, P. aeruginosa and C. albicans. Pak. J. Med. Sci., 21: 47-52. http://www.pakmedinet.com/6871
16. Hosseinzadeh, H., B.S.F. Bazzaz and M.M. Haghi, 2007. Anti-bacterial activity of total extracts and essential oil of Nigella sativa L. seeds in Mice. Pharmacology, 2: 429-435. http://www.unisa.it/download/1966_10305_2135731773_42_Hossein.pdf
17. Salman, M.T., R.A. Khan and I. Shukla, 2008. Anti-microbial activity of Nigella sativa linn. Seed oil against multi-drug resistant bacteria from clinical isolates. Nat. Prod. Rad., 7: 10-14. http://www.openmed.nic.in/2864/01/NPR-525_Rev[1].pdf
18. Toama, M.A., T.S. El-Alfy and H.M. El-Fatatry, 1974. Anti-microbial activity of volatile oil of Nigella sativa linneaus seeds. Antimicrob. Agent Chemother., 6: 225-226. http://www.ncbi.nlm.nih.gov./pubmed/15828195
19. Khan, M.A., M.K. Ashfaq, H.S. Zuberi, M.S. Mahmood and A.H. Gilani, 2003. The in vivo anti-fungal activity of the aqueous extract from Nigella sativa seeds. Phytother. Res., 17: 183-186. http://www.ncbi.nlm.nih.gov./pubmed/1260168
20. Aljabre, S.H., M.A. Randhawa, N. Akhtar, O.M. Alakloby, A.M. Alqurashi and A. Aldossary, 2005. Anti-dermatophyte activity of ether extract of Nigella sativa and its principle, thymoquinone. J. Ethnopharmacol., 101: 116-119. http://www.ncbi.nlm.nih.gov./pubmed/15908151
21. Al-Jabre, S., O.M. Al-Akloby, A.R. Al-Qurashi, N. Akhtar, A. Al-Dossary and M.A. Randhawa, 2003. Thymoquinone, an active principle of Nigella sativa, inhibited Aspergillus niger. Pak. J. Med. Res., 42: 102-104. http://www.pmrc.org.pk/NIGELLA.HTM
22. Randhawa, M.A., O.M. Al-Akloby, S.H.M. Al-jabre, A.M. Al-Qurashi and N. Akhtar, 2005. Thmoquinone, an active principle of Nigella sativa, inhibited Fusarium solani. Pak. J. Med. Res., 44: 1-3. http://www.pmrc.org.pk/PJMR44_1/1.htm
23. Chiller, K., B.A. Selkin and G.J. Murakawa, 2001. Skin microflora and bacterial infections of the skin. J. Investig. Dermato. Symp. Proc., 6: 170-174. DOI: 10.1046/j.0022-202x.2001.00043.x
24. Kugelberg, E., T. Norstrom, T.K. Peterson, T. Duvold, D.I. Andersson and D. Hughes, 2005. Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrob. Agents Chemoth., 49: 3435-3441. DOI: 10.1128/AAC.49.8.3435-3435.2005
25. Brook, I., 2002. Secondary Bacterial Infections complicating skin lesions. J. Med. Microbiol., 51: 808-812. http://www.jmm.sgmjournals.org/cgi/reprint/51/10/808
26. Duraipandiyan, V., M. Ayyanar and S. Ignacimuthu, 2006. Antimicrobial activity of some ethnomedicinal plants used by paliyr tribe from Tamil Nadu, India. BMC. Complement. Alternat. Med., 6: 35-35. DOI: 10.1186/1472-6882-6-35
27. Perez, C., M. Paul and P. Bazerque, 1990. Antibiotic assay by agar-well diffusion method. Acta Biol. Med. Exp., 15: 113-115. DOI: 10.4103/0250-474X.43012
28. Hedrich, H.H. and G. Bullock, 2006. The Laboratory Mouse: The Handbook of Experimental Animals. Elsevier Academic Press, UK., ISBN: 978-0-12-336425-8, pp: 463-492.
29. Kuo, C.F., C.C. Chen, Y.H. Luo, R.Y. Huang, W.J. Chuang, C.C. Sheu and Y.S. Lin, 2005. Cordyceps sinensis mycelium protects mice from group A streptococcal infection. J. Med. Microb., 54: 795-802. DOI: 10.1099/jmm.0.45704-0
30. Godin, B., E. Touitou, E. Rubinstein, A. Athamna and M. Athamna, 2005. A New approach for treatment of deep skin infections by an ethosomal antibiotic preparation: An in vivo study. J. Antimicrob. Chemother., 55: 989-994. DOI: 10.1093/jac/dki125
31. Enwuru, N.V., S.O. Ogbonnia, F. Nkemehule, C.A. Enwuru and O. Tolani, 2008. Evaluation of Antibacterial Activity and Acute Toxicity of the Hydroethanolic Extract of Stachytarpheta angustifolia (Mill) Vahl. Afr. J. Biotechnol., 7: 1740-1744. http://www.academicjournals.org/AJB
32. Baker, D.G., 1998. Natural pathogens of laboratory mice, rats and rabbits and their effects on research. Clin. Microbiol. Rev., 11: 231-266. http://www.cmr.asm.org/cgi/content/full/11/2/231
33. Siebenhaar, F., W. Syska, K. Weller, M. Mageril, T. zuberbier, M. Metz and M. Maurer, 2007. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. Am. J. Pathol., 170: 1910-1916. DOI: 10.2353/ajpath.2007.060770